Toll-Like Receptor-Dependent Immunomodulatory Activity of Pycnogenol®.
Annelies VerlaetNieke van der BoltBen MeijerAnnelies BreynaertTania NaessensProkopis KonstantiHauke SmidtNina HermansHuub F J SavelkoulMalgorzata TeodorowiczPublished in: Nutrients (2019)
This study showed that gastrointestinal metabolism of PYC reveals its biological activity as a potential inhibitor of TLRs signaling. The results suggest that metabolized PYC acts as a partial agonist of TLR1/2 and TLR2/6 in the presence of the microbiota-derived TLR agonists (retentate fraction) and that it possesses anti-inflammatory potential reflected by the induction of IL-10 from THP-1 macrophages (dialysate fraction).